| Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer F Saad, DM Gleason, R Murray, S Tchekmedyian, P Venner, L Lacombe, ... Journal of the National Cancer Institute 96 (11), 879-882, 2004 | 1483 | 2004 |
| Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ... Journal of the National Comprehensive Cancer Network 20 (5), 497-530, 2022 | 714 | 2022 |
| Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis T Tanvetyanon, LA Robinson, MJ Schell, VE Strong, R Kapoor, DG Coit, ... Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2008 | 402 | 2008 |
| Management of the adverse effects associated with intravenous bisphosphonates T Tanvetyanon, PJ Stiff Annals of Oncology 17 (6), 897-907, 2006 | 391 | 2006 |
| Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non–small-cell lung cancer G Simon, A Sharma, X Li, T Hazelton, F Walsh, C Williams, A Chiappori, ... Journal of Clinical Oncology 25 (19), 2741-2746, 2007 | 287 | 2007 |
| Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non–small-cell lung cancer EB Haura, T Tanvetyanon, A Chiappori, C Williams, G Simon, S Antonia, ... Journal of Clinical Oncology 28 (8), 1387, 2010 | 228 | 2010 |
| Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial BC Creelan, C Wang, JK Teer, EM Toloza, J Yao, S Kim, AM Landin, ... Nature medicine 27 (8), 1410-1418, 2021 | 212 | 2021 |
| Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements DN Hayes, AS Lucas, T Tanvetyanon, MK Krzyzanowska, CH Chung, ... Clinical Cancer Research 18 (7), 2056-2065, 2012 | 198 | 2012 |
| Beta‐carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta‐analysis and evaluation of national brands T Tanvetyanon, G Bepler Cancer 113 (1), 150-157, 2008 | 188 | 2008 |
| Randomized international phase III trial of ERCC1 and RRM1 expression–based chemotherapy versus gemcitabine/carboplatin in advanced non–small-cell lung cancer G Bepler, C Williams, MJ Schell, W Chen, Z Zheng, G Simon, S Gadgeel, ... Journal of Clinical Oncology 31 (19), 2404, 2013 | 187 | 2013 |
| Prognostic factors for survival after salvage reirradiation of head and neck cancer T Tanvetyanon, T Padhya, J McCaffrey, W Zhu, D Boulware, R DeConti, ... Journal of Clinical Oncology 27 (12), 1983-1991, 2009 | 182 | 2009 |
| Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer G Bepler, KE Sommers, A Cantor, X Li, A Sharma, C Williams, ... Journal of Thoracic Oncology 3 (10), 1112-1118, 2008 | 129 | 2008 |
| Smoking cessation, version 1.2016, NCCN clinical practice guidelines in oncology PG Shields, RS Herbst, D Arenberg, NL Benowitz, L Bierut, JB Luckart, ... Journal of the National Comprehensive Cancer Network 14 (11), 1430-1468, 2016 | 128 | 2016 |
| Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma T Tanvetyanon, D Qin, T Padhya, J McCaffrey, W Zhu, D Boulware, ... Archives of Otolaryngology–Head & Neck Surgery 135 (7), 687-692, 2009 | 124 | 2009 |
| NCCN guidelines® insights: non–small cell lung cancer, version 2.2023: featured updates to the NCCN guidelines DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ... Journal of the National Comprehensive Cancer Network 21 (4), 340-350, 2023 | 117 | 2023 |
| Phase I/Ib study of pembrolizumab plus vorinostat in advanced/metastatic non–small cell lung cancer JE Gray, A Saltos, T Tanvetyanon, EB Haura, B Creelan, SJ Antonia, ... Clinical Cancer Research 25 (22), 6623-6632, 2019 | 111 | 2019 |
| Metastatectomy for extra-cranial extra-adrenal non-small cell lung cancer solitary metastases: systematic review and analysis of reported cases S Salah, T Tanvetyanon, S Abbasi Lung cancer 75 (1), 9-14, 2012 | 111 | 2012 |
| Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analysis T Tanvetyanon, D Qin, T Padhya, R Kapoor, J McCaffrey, A Trotti American journal of otolaryngology 30 (1), 38-43, 2009 | 98 | 2009 |
| Postoperative concurrent chemotherapy and radiotherapy for high‐risk cutaneous squamous cell carcinoma of the head and neck T Tanvetyanon, T Padhya, J McCaffrey, JA Kish, RC Deconti, A Trotti, ... Head & neck 37 (6), 840-845, 2015 | 94 | 2015 |
| Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings V Kumar, K Nath, CG Berman, J Kim, T Tanvetyanon, AA Chiappori, ... Clinical nuclear medicine 38 (3), 175-182, 2013 | 89 | 2013 |
